8 Human insulin

Akre, 1964, Comparative hypoglycemic response of diabetic subjects to human insulin or structurally similar insulins of animal source, Diabetes, 13, 135, 10.2337/diab.13.2.135 Alberti, 1981, Insulin treatment and diabetes: half a century of therapeutic misadventure, 1 Alberti, 1978, Highly purified insulins, Diabetologia, 15, 77, 10.1007/BF00422248 Alberti, 1973, Inhibition of insulin secretion by somatostatin, Lancet, ii, 1299, 10.1016/S0140-6736(73)92873-0 Andres, 1966, Manual feedback technique for the control of blood glucose concentration, 486 Baker, 1981, Preliminary studies on the immunogenicity and amount of Escherichia coli polypeptides in biosynthetic human insulin produced by recombinant DNA technology, Lancet, ii, 1139, 10.1016/S0140-6736(81)90589-4 Banting, 1922, Pancreatic extracts in the treatment of diabetes mellitus, Canadian Medical Association Journal, 12, 141 Barbosa, 1980, Histocompatibility antigens in diabetic retinopathy, American Journal of Ophthalmology, 90, 148, 10.1016/S0002-9394(14)74846-9 Beggs, 1978, Transformation of yeast by a replicating hybrid plasmid, Nature, 275, 104, 10.1038/275104a0 Berson, 1966, Insulin in blood and insulin antibodies, American Journal of Medicine, 40, 676, 10.1016/0002-9343(66)90148-3 Berson, 1956, Insulin 131I metabolism in human subjects. Demonstration of insulin binding globulin in circulation of insulin treated subjects, Journal of Clinical Investigation, 35, 170, 10.1172/JCI103262 Beyer, 1981, Comparison of biosynthetic human insulin and pork insulin during rest, food ingestion and physical work in insulin-dependent diabetic subjects using a glucose controlled insulin infusion system, Diabetes Care, 4, 189, 10.2337/diacare.4.2.189 Binder, 1969, Absorption of injected insulin, Acta Pharmacologica et Toxicologica, 27, 1 Bloom, 1978, Hormonal contaminants of insulin, 318 Blundell, 1972, Insulin: the structure in the crystal and its reflection in chemistry and biology, Advances in Protein Chemistry, 26, 279, 10.1016/S0065-3233(08)60143-6 Bodansky, 1982, Genetic and immunologic factors in microvascular disease in type 1 insulin-dependent diabetics, Diabetes, 31, 70, 10.2337/diabetes.31.1.70 Botterman, 1981, Pharmacokinetics of biosynthetic human insulin and characteristics of its effect, Diabetes Care, 4, 168, 10.2337/diacare.4.2.168 Brunfeldt, 1969, Human crystalline insulin from non-diabetic and diabetic patients, Acta Endocrinologica, 60, 543, 10.1530/acta.0.0600543 Bruni, 1981, On the immunogenicity of monocomponent mixed species insulin, Minerva Endocrinologica, 6, 41 Capaldo, 1981, Blood intermediary metabolite abnormalities and free insulin levels in insulin-dependent diabetics on optimized subcutaneous insulin therapy and during 24 hours normoglycaemia using an artificial pancreas, Diabetologia, 21, 257 Carpentier, 1981, Internalization of 125I-insulin by IM-9 cultured human lymphocytes: a comparison between A14-monoiodo-pork and biosynthetic human insulin, Diabetes Care, 4, 220, 10.2337/diacare.4.2.220 Chan, 1981, The biosynthesis of insulin: some genetic and evolutionary aspects, Diabetes Care, 4, 4, 10.2337/diacare.4.1.4 Chance, 1976, The immunogenicity of insulin preparations, Acta Endocrinologica, 83, 185 Chance, 1981, Chemical, physical and biologic properties of biosynthetic human insulin, Diabetes Care, 4, 147, 10.2337/diacare.4.2.147 Crea, 1978, Chemical synthesis of genes for human insulin, 75, 5765 Deckert, 1974, The clinical significance of highly purified pig insulin preparations, Diabetologia, 10, 703, 10.1007/BF01219531 Deckert, 1972, Isoimmunization of man by recrystallized human insulin, Diabetologia, 8, 358, 10.1007/BF01218497 Deckert, 1981, Humant insulin. En landvinding?, Ugeskrift for Laeger, 143, 3199 De Meyts, 1981, In vitro studies on biosynthetic human insulin: an overview, Diabetes Care, 4, 144, 10.2337/diacare.4.2.144 De Meyts, 1978, Mapping of the residues in the receptor-binding region of insulin responsible for the negative cooperativity, Nature, 273, 504, 10.1038/273504a0 Dixon, 1960, Regeneration of insulin activity from the separated and inactive A and B chains, Nature, 188, 721, 10.1038/188721a0 Dixon, 1975, Insulin antibodies and the control of diabetes, Quarterly Journal of Medicine, 176, 543 Economist, 1982, Biotech woes, The Economist, 96 Federlin, 1981, Biologic and immunologic in vivo and in vitro studies with biosynthetic human insulin, Diabetes Care, 4, 170, 10.2337/diacare.4.2.170 Gale, 1980, search of the Somogyi effect, Lancet, ii, 279, 10.1016/S0140-6736(80)90233-0 Galloway, 1981, The plasma glucose response of normal fasting subjects to neutral, regular and NPH biosynthetic human and purified pork insulins, Diabetes Care, 4, 183, 10.2337/diacare.4.2.183 Gattner, 1980, Enzyme-catalysed semi-synthesis with insulin derivatives, 117 Gerlis, 1981, Porcine and semi-synthetic human insulins: a comparison of their metabolism in man, Diabetologia, 21, 274 Gilbert, 1979, Useful proteins from recombinant bacteria, Scientific American, 242, 68 Goeddel, 1979, Expression in E. coli of chemically synthesised genes for human insulin, 76, 106 Hagedorn, 1936, Protamine insulinate, Journal of the American Medical Association, 106, 177, 10.1001/jama.1936.02770030007002 Hallas-Møller, 1952, Zinc insulin preparations for single daily injection, Journal of the American Medical Association, 150, 1667, 10.1001/jama.1952.03680170021006 Hansen, 1981, Immunogenicity of insulin as a function of species and other factors, 55 Hansen, 1982, New approaches to therapy and diagnosis of diabetes, Diabetologia, 22, 61, 10.1007/BF00254830 Home, 1982, The new insulins, a review of their characteristics and clinical indications, Drugs, 10.2165/00003495-198224050-00003 Home, 1982, Some observations on insulin absorption and pharmacokinetics Home, 1981, Continuous subcutaneous insulin infusion: comparison of plasma insulin profiles after infusion or bolus injection of the meal-time dose, Metabolism, 30, 439, 10.1016/0026-0495(81)90177-3 Home, 1982, A comparison of the activity and disposal of semi-synthetic human insulin and porcine insulin in normal man by the glucose clamp technique, Diabetologia, 22, 41, 10.1007/BF00253868 Home, 1982, A new look at the pharmacokinetics of subcutaneously injected human and porcine insulin, Diabetes, 31, 58A Inouye, 1979, Enzyme-assisted semi-synthesis of human insulin, Journal of the American Chemical Society, 101, 751, 10.1021/ja00497a051 Jackson, 1982, Insulin 1922–1982, International Diabetes Federation Bulletin, 27, 9 Jorpes, 1949, Recrystallized insulin for diabetic patients with insulin allergy, Archives of Internal Medicine, 83, 363, 10.1001/archinte.1949.00220330003001 Keefer, 1981, Receptor binding properties and biologic activity in vitro of biosynthetic human insulin, Diabetes Care, 4, 209, 10.2337/diacare.4.2.209 Keen, 1982 Keen, 1980, Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men, Lancet, ii, 398, 10.1016/S0140-6736(80)90443-2 Keen, 1982, Biosynthetic human insulin: metabolic and hormonal responses in normal man, Diabetologia, 22, 388 Kilo, 1980, The crux of the UGDP, Diabetologia, 18, 179, 10.1007/BF00251913 Kimmell, 1967, Studies of human insulin from diabetic and non-diabetic pancreas, Diabetes, 16, 687, 10.2337/diab.16.10.687 Klier, 1981, Comparison of the biologic activity of biosynthetic human insulin and natural pork insulin in juvenile-onset diabetic subjects assessed by the glucose controlled insulin infusion system, Diabetes Care, 4, 193, 10.2337/diacare.4.2.193 Kung, 1966, Total synthesis of crystalline insulin, Scientia Sinica, 15, 544 Kurtz, 1980, Circulating insulin binding antibodies, Diabetologia, 19, 329, 10.1007/BF00280515 Laube, 1981, Semisynthetisches Humaninsulin — vergleichende Untersuchung über Stoffwechseleffekte beim Menschen, Aktuelle Endokrinologie und Stoffwechsel, 2, 102 Marki, 1977, Biological activity of synthetic human insulin, Diabetologia, 13, 293, 10.1007/BF01223268 Markussen, 1977, Synthetic paths to insulin, Acta Paediatrica Scandinavia, 270, 121, 10.1111/j.1651-2227.1977.tb15132.x Massi-Benedetti, 1981, A comparative study of the activity of biosynthetic human insulin and pork insulin using the glucose clamp technique in normal subjects, Diabetes Care, 4, 163, 10.2337/diacare.4.2.163 Mirsky, 1963, The isolation and crystallization of human insulin, Journal of Clinical Investigation, 12, 1869, 10.1172/JCI104871 Morihara, 1979, Semi-synthesis of human insulin by trypsincatalysed replacement of Ala-B30 by Thr in porcine insulin, Nature, 280, 412, 10.1038/280412a0 National Diabetes Advisory Board, 1978, A Study of Insulin Supply and Demand, US Department of Health, Education and Welfare (NIH), 78, 1588 Nicol, 1960, Amino-acid sequence of human insulin, Nature, 187, 483, 10.1038/187483a0 Nosadini, 1982, The metabolic response to normoglycaemia in insulin-dependent diabetics: studies with a glucose-controlled insulin infusion system (artificial endocrine pancreas), Diabetologia, 10.1007/BF00252845 Oakley, 1978 Obermeier, 1976, A new semisynthesis of human insulin, Hoppe-Seyler's Zeitschrift für Physiologische Chemie, 357, 759, 10.1515/bchm2.1976.357.1.759 Owens, 1981, Human insulin: study of safety and efficacy in man, British Medical Journal, 282, 1264, 10.1136/bmj.282.6272.1264 Owens, 1982, A study of the comparative safety and efficacy of neutral soluble human insulin (semi-synthetic) and porcine monocomponent insulin in non-diabetic subjects, Diabete et Metabolism Paulesco, 1921, Recherches sur le rôle du pancreas dans I'assimilation nutritive, Archives of Internal Physiology, 17, 85 Raptis, 1981, Comparison of insulin requirements between porcine and biosynthetic human insulin assessed by the artificial endocrine pancreas, Diabetes, 30, 10A Raptis, 1981, Biologic activities of biosynthetic human insulin in healthy volunteers and insulin-dependent diabetic patients monitored by the artificial endocrine pancreas, Diabetes Care, 4, 155, 10.2337/diacare.4.2.155 Root, 1981, Factors affecting the measurement of insulin in the blood of human subjects following the administration of purified pork and human insulin, Diabetologia, 21, 321 Roth, 1982, The evolutionary origins of hormones, neurotransmitters and other extracellular chemical messengers. Implications for mammalian biology, New England Journal of Medicine, 306, 523, 10.1056/NEJM198203043060907 Ryle, 1955, The disulphide bonds of insulin, Biochemical Journal, 60, 541, 10.1042/bj0600541 Schernthaner, 1981, Analysis of insulin antibodies following human or pork MC insulin therapy in HLA-DR typed juvenile diabetics: a prospective study, Diabetologia, 21, 324 Schluter, 1980, Gegenregulation der Hypoglykamie nach synthetischem Humaninsulin im Vergleich zum Schweineinsulin, Aktuelle Endokrinologie und Stoffwechsel, 2, 201 Schluter, 1982, Klinische Erfahrungen mit Humaninsulin, Deutsche Medizinische Wochenschrift, 107, 10, 10.1055/s-2008-1069862 Schluter, 1981, Effects of fully synthetic human insulin in comparison to porcine insulin in normal subjects, Hormone and Metabolic Research, 13, 657, 10.1055/s-2007-1019367 Scott, 1936, Studies on insulin with protamine, Journal of Pharmacology and Experimental Therapeutics, 58, 78 Sestoft, 1982, The biological properties of human insulin: subcutaneous absorption, receptor binding and the clinical effect in diabetics assessed by a new statistical method, Acta Medica Scandinavia Shapcott, 1970, A method for the isolation of insulin from single human pancreas, Diabetes, 19, 831, 10.2337/diab.19.11.831 Shepherd, 1981, A comparison of the activity of insulins from different species injected subcutaneously in insulin-dependent diabetics (IDD) using the glucose clamp technique, Diabetologia, 21, 327 Sieber, 1974, Total Synthese von Humaninsulin Gezielter Bildung der Disulfidbindungen, Helvetica Chimica Acta, 57, 2617, 10.1002/hlca.19740570839 Sonksen, 1977, The evolution of insulin treatment, Clinics in Endocrinology and Metabolism, 6, 481, 10.1016/S0300-595X(77)80048-0 Sonksen, 1973, A comparative study on the metabolism of human insulin and porcine proinsulin in man, Clinical Science and Molecular Medicine, 45, 633 Staten, 1982, Euglycaemic insulin clamp dose-response comparisons of purified porcine and semi-synthetic human insulins in insulin-dependent diabetes, Clinical Research, 30, A103 Steiner, 1968, Isolation and properties of proinsulin, intermediate forms, and other minor components from crystalline bovine insulin, Diabetes, 17, 725, 10.2337/diab.17.12.725 Steiner, 1972, The biosynthesis of insulin, 175 Sundermann, 1981, Absorptionskinetik und biologische Activität von semisynthetischem Human-Insulin (Novo), Aktuelle Endokrinologie und Stoffwechsel, 2, 116 Szekeres, 1982, Comparative study of the biological activity of purified porcine and semi-synthetic human insulin using the glucose controlled insulin infusion system in insulin-dependent diabetic patients, Clinical Research, 30, A65 Tager, 1979, A structurally abnormal insulin causing human diabetes, Nature, 281, 122, 10.1038/281122a0 Tchobroutsky, 1978, Relation of diabetic control to development of microvascular complications, Diabetologia, 15, 143, 10.1007/BF00421230 Teuscher, 1979, Die biologische Wirkung von vollsynthetischem humanem Insulin bei Patienten mit Diabetes mellitus, Schweizer Medizinische Wochenschrift, 109, 743 Teuscher, 1980, Do fully synthetic and genetically synthesised human insulin differ?, Lancet, ii, 1186, 10.1016/S0140-6736(80)92612-4 Turner, 1971, Measurement of the insulin delivery rate in man, Journal of Clinical Endocrinology and Metabolism, 33, 279, 10.1210/jcem-33-2-279 Ullrich, 1977, Rat insulin genes: construction of plasmids containing the coding sequences, Science, 496, 1313, 10.1126/science.325648 Villa-Komaroff, 1978, A bacterial clone synthesizing proinsulin, 75, 3727 Walford, 1982, The effect of insulin antibodies on insulin dose and diabetic control, Diabetologia, 22, 106, 10.1007/BF00254838 Weinges, 1981, Comparison of biosynthetic human insulin and pork insulin in the Gerritzen test, Diabetes Care, 4, 180, 10.2337/diacare.4.2.180 World Health Organization, 1980 Worth, 1980, Increased patient attention or home blood glucose monitoring as major determinants of improved diabetic control, Diabetologia, 19, 565